Multiple endocrine neoplasia type 1 laboratory findings: Difference between revisions
| Line 15: | Line 15: | ||
:* [[C-peptide]] | :* [[C-peptide]] | ||
:* [[Proinsulin]] | :* [[Proinsulin]] | ||
:* [[Serum cortisol]] | :* [[Cortisol|Serum cortisol]] | ||
==Reference== | ==Reference== | ||
Revision as of 16:43, 11 September 2015
|
Multiple endocrine neoplasia type 1 Microchapters |
|
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multiple endocrine neoplasia type 1 laboratory findings On the Web |
|
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 laboratory findings |
|
FDA on Multiple endocrine neoplasia type 1 laboratory findings |
|
CDC on Multiple endocrine neoplasia type 1 laboratory findings |
|
Multiple endocrine neoplasia type 1 laboratory findings in the news |
|
Blogs on Multiple endocrine neoplasia type 1 laboratory findings |
|
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
|
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [3]
Overview
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 1 include increased parathyroid hormone, increased gastrin, and increased cortisol.
Laboratory Findings
- Laboratory tests may be performed periodically to screen for multiple endocrine neoplasia type 1 tumors[1]
- Parathyroid hormone
- Prolactin
- Insulin
- Urinary calcium to detect the results of excess hormone production
- Gastrin
- Insulin
- Glucose
- C-peptide
- Proinsulin
- Serum cortisol